|
CNN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.09870018533331E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.94619999694635E-08 |
| Normal-vs-Stage2 |
9.4418999996293E-07 |
| Normal-vs-Stage3 |
2.568800E-04 |
| Normal-vs-Stage4 |
3.604800E-04 |
| Stage1-vs-Stage2 |
4.262000E-01 |
| Stage1-vs-Stage3 |
3.820200E-01 |
| Stage1-vs-Stage4 |
8.058200E-01 |
| Stage2-vs-Stage3 |
1.302020E-01 |
| Stage2-vs-Stage4 |
5.880800E-01 |
| Stage3-vs-Stage4 |
4.384600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.50249878783893E-11 |
| Normal-vs-AfricanAmerican |
1.9474999999991E-05 |
| Normal-vs-Asian |
5.377900E-03 |
| Caucasian-vs-AfricanAmerican |
2.163200E-01 |
| Caucasian-vs-Asian |
7.907600E-01 |
| AfricanAmerican-vs-Asian |
5.494400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79112280562777E-12 |
| Normal-vs-Female |
3.171600E-04 |
| Male-vs-Female |
5.603600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.0800000000063E-05 |
| Normal-vs-Extreme_Weight |
4.71169991911324E-10 |
| Normal-vs-Obese |
2.18039999999586E-06 |
| Normal-vs-Extreme_Obese |
4.012400E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.711800E-01 |
| Normal_Weight-vs-Obese |
8.408200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.609200E-01 |
| Extreme_Weight-vs-Obese |
2.318600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.284600E-01 |
| Obese-vs-Extreme_Obese |
5.240800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.92359999987113E-07 |
| Normal-vs-Age(61-80Yrs) |
1.45280010244164E-10 |
| Normal-vs-Age(81-100Yrs) |
1.171170E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.714800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.342000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.475200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.884200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.590400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.431600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62636570877339E-12 |
| Normal-VS-Type2 PRCC |
2.412500E-04 |
| Normal-VS-KIRP CIMP |
8.436800E-04 |
| Normal-VS-Unclassified PRCC |
4.12730000000083E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.776900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.867000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.666000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.535600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.965600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.166000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.98340000376629E-08 |
| Normal-vs-N1 |
1.584800E-04 |
| Normal-vs-N2 |
9.784100E-02 |
| N0-vs-N1 |
3.318200E-01 |
| N0-vs-N2 |
5.586600E-01 |
| N1-vs-N2 |
8.861600E-01 |
|
|
